Bioengineered human skin: Working the bugs out

Molecular Therapy

Volumn 17, Issue 3, 2009, Pages 405-408

  Steinstraesser, L ^a   Al Benna, S ^a   Kesting, M ^b   Jacobsen, F ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; POLYPEPTIDE ANTIBIOTIC AGENT; VIRUS VECTOR;

ACINETOBACTER BAUMANNII; ADAPTIVE IMMUNITY; ANGIOGENESIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; BIOENGINEERING; CELL BASED GENE THERAPY; CELL FUNCTION; CHEMOTAXIS; CYTOKINE PRODUCTION; DNA MODIFICATION; GENETIC ENGINEERING; HISTAMINE RELEASE; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; INFECTION RISK; INNATE IMMUNITY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NOTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK REDUCTION; SKIN DISEASE; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; WOUND HEALING; WOUND INFECTION;

EID: 61649119898     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.14     Document Type: Note

References (31)

1. Bowler, PG (2002). Wound pathophysiology, infection and therapeutic options. Ann Med 34: 419-427.
2. Howell-Jones, RS, Wilson, MJ, Hill, KE, Howard, AJ, Price, PE, Thomas, DW (2005). A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 55: 143-149.
3. Steinstraesser, L, Koehler, T, Jacobsen, F, Daigeler, A, Goertz, O, Langer, S et al. (2008). Host defense peptides in wound healing. Mol Med 14: 528-537.
4. Kaus, A, Jacobsen, F, Sorkin, M, Rittig, A, Voss, B, Daigeler, A et al. (2008). Host defence peptides in human burns. Burns 34 32-40.
5. Jacobsen, F, Mohammadi-Tabrisi, A, Hirsch, T, Mittler, D, Mygind, PH, Sonksen, CP et al. (2007). Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin. J Antimicrob Chemother 59: 493-498.
6. Hirsch, T, von Peter, S, Dubin, G, Mittler, D, Jacobsen, F, Lehnhardt, M et al. (2006). Adenoviral gene delivery to primary human cutaneous cells and burn wounds. Mol Med 12: 199-207.
7. Steinstraesser, L, Tippler, B, Mertens, J, Lamme, E, Homann, HH, Lehnhardt M et al. (2005). Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology 2: 2.
8. Jacobsen, F, Mittler, D, Hirsch, T, Gerhards, A, Lehnhardt, M, Voss, B et al. (2005) Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Ther 12: 1494-1502.
9. Thomas-Virnig, CL, Centanni, JM, Johnston, CE, He, L-K, Schlosser, SJ, Van Winkle, KF et al. (2009). Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue. Mol Ther 17: 562-569.
10. Kaus, A, Jacobsen, F, Sorkin, M, Rittig, A, Voss, B, Daigeler, A et al. (2008). Host defence peptides in human burns. Burns 34 32-40.
11. Hirsch, T, Jacobsen, F, Steinau, HU and Steinstraesser, L (2008). Host defense peptides and the new line of defence against multiresistant infections. Protein Pept Lett 15: 238-243.
12. Larrick, JW, Hirata, M, Balint, RF, Lee, J, Zhong, J and Wright, SC (1995). Human CAP18: A novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 63: 1291-1297.
13. Zasloff, M (2002). Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
14. Steinstraesser, L, Burghard, O, Nemzek, J, Fan, MH, Merry, A, Remick, DI et al. (2003). Protegrin-1 increases bacterial clearance in sepsis but decreases survival. Crit Care Med 31: 221-226.
15. Steinstraesser, L, Tack, BF, Waring, AJ, Hong, T, Boo, LM, Fan, MH et al. (2002). Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob Agents Chemother 46: 1837-1844.
16. Nizet, V, Ohtake, T, Lauth, X, Trowbridge, J, Rudisill, J, Dorschner, RA et al. (2001). Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
17. Steinstraesser, L, Oezdogan, Y, Wang, SC and Steinau, HU (2004). Host defense peptides in burns. Burns 30: 619-627.
18. Steinstraesser, L, Ring, A, Bals, R, Steinau, HU and Langer, S (2006). The human host defense peptide LL37/hCAP accelerates angiogenesis in PEGT/PBT biopolymers. Ann Plast Surg 56: 93-98.
19. Murakami, M, Ohtake, T, Dorschner, RA, Schittek, B, Garbe, C and Gallo, RL (2002). Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 119: 1090-1095.
20. Zaiou, M, Nizet, V, Gallo, RL (2003). Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120: 810-816.
21. Koczulla, R, von Degenfeld, G, Kupatt, C, Krotz, F, Zahler, S, Gloe, T et al. (2003). An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111: 1665-1672.
22. Shaykhiev, R, Beisswenger, C, Kandler, K, Senske, J, Puchner, A, Damm, T et al. (2005). Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 289: L842-L848.
23. Dorschner, RA, Pestonjamasp, VK, Tamakuwala, S, Ohtake, T, Rudisill, J, Nizet, V et al. (2001). Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117: 91-97.
24. Heilborn, JD, Nilsson, MF, Kratz, G, Weber, G, Sorensen, O, Borregaard, N et al. (2003). The cathelicidin anti-microbial peptide LL-37 is involved in reepithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 120: 379-389.
25. Heilborn, JD, Nilsson, MF, Jimenez, CI, Sandstedt, B, Borregaard, N, Tham, E, et al. (2005). Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer 114: 713-719.
26. Kurosaka, K, Chen, Q, Yarovinsky, F, Oppenheim, JJ and Yang, D (2005). Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol 174 6257-6265.
27. Territo, MC, Ganz, T, Selsted, ME and Lehrer, R (1989). Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 84: 2017-2020.
28. Gallo, RL, Ono, M, Povsic, T, Page, C, Eriksson, E, Klagsbrun, M et al. (1994). Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA 91: 11035-11039.
29. Li, J, Post, R, Volk, R, Gao, Y, Li, M, Metais, C et al. (2000). PR39, a peptide regulator of angiogenesis. Nat Med 6: 49-55.
30. Terskikh, VV and Vasiliev, AV (1999). Cultivation and transplantation of epidermal keratinocytes. Int Rev Cytol 188: 41-72.
31. Vogel, JC (2000). Nonviral skin gene therapy. Hum Gene Ther 11 2253-2259.